Sung Gyun Kim

A Phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy.

R. Lafayette, Rubeen K. Israni, Jonathan Barratt, 2024, Kidney international.